Viking Therapeutics’ GLP-1 pill candidate for treating obesity showed promise in its latest trial results, the clinical-stage ...

Amgen’s MariTide, targeting both GIPR and GLP-1R, could become a significant player in the weight-loss market, though safety concerns ... ranging from -7.2% at the lowest dose (120mg) to -14.5% at the ...

Medically reviewed by Kelly Wood, MD Hypothyroidism—or an underactive thyroid—is a condition that happens when the thyroid ...

HCG, a global leader in the field, has recently reorganised seven smaller agencies into a single, powerful entity with a clear purpose: to accelerate the impact of science for its pharmaceutical ...

The biotech had tested the oral asset, dubbed VK2735, at doses ranging from 2.5 mg up to 100 mg. Viking already revealed back in March that 25% of the eight patients who received 20-mg doses saw their ...

Twenty-three pounds of weight loss later, she’s figuring out how low of a dose she can use. “I don’t want to lose any more weight,” she said. “But I also don’t want to gain the weight ...

Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.

As demand for popular weight-loss drugs like Wegovy and Zepbound skyrockets, patients are taking dosage amounts into their ...

The lowest dose of Novo Nordisk's weight-loss drug, Wegovy, was listed as available on the U.S. health regulator's website on Wednesday.

Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...